简介：
Overview
This article presents a protocol for creating an immunocompetent ICR murine model to study dengue virus-induced neuropathy. The model allows for monitoring acute viral encephalitic disorders in vivo.
Key Study Components
Area of Science
- Neuroscience
- Infectious Diseases
- Animal Models
Background
- Dengue virus can cause neurological complications.
- Existing models may not effectively represent neuropathogenesis.
- The ICR murine model provides a new platform for research.
- Low viral titer infection is utilized for better disease induction.
Purpose of Study
- To develop a reliable model for studying dengue virus effects on the central nervous system.
- To facilitate screening of viral and host factors involved in neuropathogenesis.
- To monitor disease progression using standardized scoring methods.
Methods Used
- Infection of immunocompetent ICR suckling mice.
- Dilution of non-adapted dengue virus to a specific titer.
- Use of syringes with precise volumes for virus administration.
- Monitoring of disease symptoms and progression.
Main Results
- Successful induction of encephalitic-like disease in mice.
- Establishment of a protocol for future studies on neuropathogenesis.
- Demonstration of the model's utility in screening interventions.
- Standardized scoring system for assessing disease severity.
Conclusions
- The ICR murine model is effective for studying dengue virus neuropathy.
- This protocol can aid in understanding viral and host interactions.
- Future research can build on this model to explore therapeutic options.
What is the significance of using an immunocompetent model?
Using an immunocompetent model allows for a more accurate representation of the disease as it occurs in humans, providing insights into the immune response to dengue virus.
How does this model differ from previous models?
This model uses a low viral titer for infection, which can better mimic natural infection conditions and enhance the study of neuropathogenesis.
What are the main applications of this protocol?
The protocol can be used for screening potential antiviral treatments and understanding the mechanisms of dengue virus-induced neuropathy.
Who demonstrated the procedure in the article?
The procedure was demonstrated by Ting-Jing Shen, a PhD candidate from the laboratory.
What are the expected outcomes of using this model?
Expected outcomes include a better understanding of disease progression and the identification of factors contributing to neuropathogenesis.
Can this model be adapted for other viral infections?
Yes, the model can potentially be adapted for studying other viral infections that affect the central nervous system.
繁體中文
